Page last updated: 2024-08-25

cipamfylline and Dermatitis, Irritant

cipamfylline has been researched along with Dermatitis, Irritant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ashikaga, T; de Jongh, GJ; Hornix, M; Kucharekova, M; Schalkwijk, J; T'kint, S; van de Kerkhof, PC; van der Valk, PG	1

Trials

1 trial(s) available for cipamfylline and Dermatitis, Irritant

Article	Year
The effect of the PDE-4 inhibitor (cipamfylline) in two human models of irritant contact dermatitis. Archives of dermatological research, 2003, Volume: 295, Issue:1 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Betamethasone Valerate; Cell Division; Cyclic Nucleotide Phosphodiesterases, Type 4; Dermatitis, Irritant; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Erythema; Female; Glucocorticoids; Humans; Keratins; Male; Middle Aged; Pilot Projects; Sodium Dodecyl Sulfate; Surface-Active Agents; Water Loss, Insensible; Xanthines	2003

Article

Year

The effect of the PDE-4 inhibitor (cipamfylline) in two human models of irritant contact dermatitis.

Archives of dermatological research, 2003, Volume: 295, Issue:1

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Betamethasone Valerate; Cell Division; Cyclic Nucleotide Phosphodiesterases, Type 4; Dermatitis, Irritant; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Erythema; Female; Glucocorticoids; Humans; Keratins; Male; Middle Aged; Pilot Projects; Sodium Dodecyl Sulfate; Surface-Active Agents; Water Loss, Insensible; Xanthines

2003